LM-2417

· LaNova Medicines Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LM-2417, covering 2025-09-25 to 2025-09-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours [Phase 1, Phase 2]